Lv5
1520 积分 2022-10-25 加入
Preclinical and Clinical Development of Exatecan (DX-951f)
19天前
已完结
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
22天前
已完结
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
22天前
已完结
Population PK analysis of DX-8951F when administered to cancer patients
23天前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
28天前
已完结
Semimechanistic model to characterize nonlinear pharmacokinetics of nimotuzumab in patients with advanced breast cancer
29天前
已完结
Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies
1个月前
已完结
Discovery of a High-Potency Balanced GLP-1/GIP Dual Agonist by Molecular Dynamics Evolution
1个月前
已完结
Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology
2个月前
已完结
Model-Informed individualized dosage regimen of sirolimus in pediatric patients with intractable lymphatic malformations
2个月前
已完结
皖公网安备34019202002308
